Delivery Order SPE2DB22D3004-SPE2DB24FRP85
Award Date
8/23/24
Potential Completion Date
8/26/24
Potential Value
$1.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of Atomoxetine HCL 18 mg capsules, with a ceiling value of $2,205.42 and a performance period extending to May 27, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite...
This federal contract award, valued at $1,699.95, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a pharmaceutical distributor, for the delivery of Atomoxetine HCL 40 mg capsules. The contract has a completion date of February 13, 2024 and is a firm fixed-price delivery order. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary...
This federal contract award is for the delivery of Atomoxetine HCL 80 mg capsules to the Defense Logistics Agency (DLA). The contract has an ultimate completion date of September 19, 2024 and a ceiling value of $1,252.34. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on September 18, 2024. This is a delivery order contract with a firm fixed price pricing type. The contract is not designated under any set-aside program. Amerisourcebergen holds a...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the delivery of 18 mg capsules of the drug Atomoxetine HCL, with a ceiling value of $1,180.72 and a completion date of April 9, 2025. The contract is a Delivery Order, with a Firm Fixed Price pricing type. It is not designated as a set-aside contract. Amerisourcebergen Drug Corp is the prime contractor, and there are no major...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,603.09 firm fixed-price delivery order is for the provision of 4,563,867,448 units of the medication Atomoxetine HCL 25 mg capsules. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award is for the delivery of Atomoxetine HCL 80 mg capsules to the Defense Logistics Agency (DLA) Troop Support Medical, which is a component of the U.S. Department of Defense. The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., which is a major pharmaceutical distribution company. The contract is a firm fixed-price delivery order with a ceiling value of $3,287.50 and an ultimate completion date of September 19, 2023....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,547.45 firm fixed-price delivery order is for the supply of 4,567,240,539 units of Atomoxetine HCL 40 mg capsules. The contract has an ultimate completion date of February 13, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award, solicitation number SPE2DB20D1004|SPE2DB24FF1R7, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,992.79 firm fixed-price delivery order is for the supply of 80 mg Atomoxetine HCL capsules. The contract has an ultimate completion date of January 8, 2024 and was awarded on January 5, 2024. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract...
This federal contract award, with a ceiling value of $1,126.22, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Atomoxetine HCL 40 mg capsules, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract does not have a set-aside designation, indicating it was open to full and open competition. AmerisourceBergen holds a...
This federal contract award is for the delivery of Atomoxetine HCL 25 mg capsules to the Defense Logistics Agency (DLA), a defense agency. The $1,008.04 firm-fixed-price delivery order was issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, under the company's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical. This IDC serves as the primary vehicle for AmerisourceBergen to provide a comprehensive range of pharmaceutical products and medical...